Beclometasone/Formoterol Zentiva

Beclometasone/Formoterol Zentiva is a combination inhaler used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication combines an anti-inflammatory corticosteroid with a long-acting bronchodilator to improve breathing. It is designed for inhalation use and is manufactured by Zentiva France.

Beclometasone/Formoterol Zentiva is primarily used for the maintenance treatment of asthma and COPD. The beclometasone component helps reduce inflammation in the airways, while formoterol works as a bronchodilator to relax the muscles around the airways, making it easier to breathe. This combination is often prescribed for individuals who require both anti-inflammatory and bronchodilator effects to manage their respiratory conditions effectively.

Common effects of Beclometasone/Formoterol Zentiva may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Beclometasone/Formoterol Zentiva should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to minimize the risk of oral thrush. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their use of this medication with their doctor. Always follow the prescribed dosage and administration instructions.

Beclometasone/Formoterol Zentiva may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is also advisable to avoid using this inhaler with other long-acting beta-agonists without medical supervision. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.